Continuous Glucose Monitoring Device (Energy Harvesting & Storage USA 2010)

Mr Ioannis Tomazos
United States
Nov 17, 2010.


Biorasis Presentation*
Biorasis Audio*

If you already have access, please [Login]

Presentation Summary

  • Diabetes and the health care system and the need for a reliable continuous glucose monitoring system
  • The current market and end technological developments
  • Our approach and current developments

Speaker Biography (Ioannis Tomazos)

Ioannis Tomazos, PhD, MBA. Dr. Tomazos was appointed as the CEO of Biorasis Inc. in 2008. Dr. Tomazos received a Doctoral degree in Cellular Biology and a Masters in Business Administration in Marketing from the University of Connecticut (UCONN). In the school of business he worked as a consultant for three businesses in the State of Connecticut, as a research assistant at the Office of Technology Commercialization of UCONN and completed an internship at Well Point. He has several publications and patents.

Company Profile (Biorasis Inc)

Biorasis Inc logo
Biorasis Inc is developing needle-implantable glucose and other bio-analyte biosensors for use in drug development research, as well as for human on-demand metabolic disease management. Our technology includes both a miniaturized (0.5 mm x 0.5 mm x 5 mm) sensor platform (equipped with power source, signal processors and wireless communication), as well as biocompatible coatings that enables functioning of sensors for a period of 3 months. The continuous monitoring of body bio-analytes is key in the diagnosis, prognosis and treatment of diseases, such as diabetes, atherosclerosis, liver and kidney abnormalities, etc.
View Biorasis Inc Timeline